Corynoxine B has shown potential in neuropharmacological research due to its ability to modulate dopaminergic activity. It is being studied for its effects on neurodegenerative diseases, particularly Parkinson's disease, as it may help regulate dopamine levels and protect neurons. Additionally, it has been explored for its anti-inflammatory and antioxidant properties, which could contribute to therapeutic applications in conditions involving oxidative stress and inflammation. Research is ongoing to further understand its mechanisms and potential clinical uses.